Analysis of 2215 intensive care unit patients showing no significant differences with this very late stage use of HCQ. HCQ+AZ mortality relative risk RR 0.96, p=0.53, HCQ and HCQ+AZ combined RR 1.06, p=0.409.
This study is excluded in the after exclusion results of meta
very late stage, >50% on oxygen/ventilation at baseline.
risk of death, 6.0% higher, RR 1.06, p = 0.41, treatment 631 of 1,761 (35.8%), control 153 of 454 (33.7%).
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Gupta et al., 15 Jul 2020, retrospective, USA, peer-reviewed, baseline oxygen required 87.1%, 34 authors.